Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany-Reference-Cited by-同舟云学术

Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany

Published:2022-01-16 Issue:3 Volume:39 Page:1247-1266
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Steinmetz H. Tilman^ORCID,Singh Moushmi,Milce Joseph,Haidar Mohamad,Rieth Achim,Lebioda Andrea,Kohnke Jörn

Funder

Amgen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-021-02022-z.pdf

Reference40 articles.

1. Bobin A, Liuu E, Moya N, et al. Multiple myeloma: an overview of the current and novel therapeutic approaches in 2020. Cancers (Basel). 2020;12(10):2885. https://doi.org/10.3390/cancers12102885.

2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403. https://doi.org/10.1016/j.ejca.2012.12.027.

3. Robert Koch Institute. Cancer in Germany in 2015/2016. 12th ed. Berlin: Robert Koch Institute; 2020.

4. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33. https://doi.org/10.4065/78.1.21.

5. Ninkovic S, Quach H. Shaping the treatment paradigm based on the current understanding of the pathobiology of multiple myeloma: an overview. Cancers (Basel). 2020;12(11):3488. https://doi.org/10.3390/cancers12113488.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany;Bone Marrow Transplantation;2024-03-14

2. Real‐world treatment patterns in patients initiating third‐line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain;European Journal of Haematology;2023-12-25

3. Estimation of eligibility for and response to CAR-T therapy in the United States;Blood Advances;2023-12-01

4. Real‐world experience of novel multiple myeloma treatments in a large, single‐center cohort in Finland;eJHaem;2023-10-06

5. Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review;Journal of Clinical Medicine;2023-09-22